StonvexLoading…
StonvexStonvexStonvexCore line items from PKE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-11-30 | Q3 2025 2025-08-31 | Q2 2025 2025-06-01 | Annual 2025 2025-03-02 |
|---|---|---|---|---|
Revenue | $49.11M | $31.78M | $15.40M | $62.03M |
Operating Income | $8.91M | $5.26M | $2.42M | $9.40M |
Net Income | $7.43M | $4.48M | $2.08M | $5.88M |
EPS (Diluted) | $0.37 | $0.22 | $0.10 | $0.29 |
Total Assets | $118.10M | $116.45M | $120.72M | $122.11M |
Total Liabilities | $11.51M | $10.65M | $15.77M | $14.95M |
Cash & Equivalents | $50.50M | $29.54M | $20.62M | $21.62M |
Free Cash Flow OCF − CapEx | $3.08M | $-1.19M | $1.11M | $3.83M |
Shares Outstanding | 20.02M | 19.98M | 19.97M | 20.19M |